Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Biotricity, Inc. - Common Stock (NQ:BTCY)

0.4631 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Biotricity, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Biotricity To Host Fiscal 2023 Third Quarter Financial Results Call on February 14th at 4:30pm ET
Via ACCESSWIRE
News headline image
Biotricity Selected to Present its Work on AI Enabled Stroke Prediction in CKD Patients at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference
Via ACCESSWIRE
News headline image
Biotricity Signs Distribution Agreement With Top 5 Distributor for its Cardiac Monitoring Solutions
Via ACCESSWIRE
News headline image
Biotricity to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th at 8:15 A.M. ET
Via ACCESSWIRE
News headline image
Biotricity Signs with Top 5 Group Purchasing Organization; Potential for Higher Sales Volume in 2023
Via ACCESSWIRE
News headline image
Biotricity Surpasses $10 Million in Annual Revenue Run Rate
Via ACCESSWIRE
News headline image
Biotricity Provides Updates on its Operational and Expansion Strategy
Via ACCESSWIRE
News headline image
Biotricity Reports Financial Results for Fiscal 2023 Second Quarter
Via ACCESSWIRE
News headline image
Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth
Via ACCESSWIRE
News headline image
Biotricity Signs Distribution Agreement to Expand Access for its Cardiac Monitoring Solutions
Via ACCESSWIRE
News headline image
Biotricity's Bioheart Named to TIME's List of The Best Inventions of 2022
Via ACCESSWIRE
News headline image
Biotricity to Host Fiscal 2023 Second Quarter Financial Results on November 14th at 4:30 PM ET
Via ACCESSWIRE
News headline image
Biotricity Launches Cardiac Disease Management Solution Following 2 Successful Pilots with Oklahoma & Kentucky Clinics
Via ACCESSWIRE
News headline image
Biotricity CEO, Waqaas Al-Siddiq, to Participate in Panel Discussion on the Evolution of Medical Devices at the American Medical Device Summit on October 19th
Via ACCESSWIRE
News headline image
Biotricity Surpasses 2 billion Recorded and Analyzed Heartbeats for Atrial Fibrillation (AFib)
Via ACCESSWIRE
News headline image
Biotricity Wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled Real-Time Monitoring and Predictive Analytics for Stroke due to Chronic Kidney Failure
Via ACCESSWIRE
News headline image
Biotricity Reports Financial Results for Fiscal 2023 First Quarter
Via ACCESSWIRE
News headline image
Biotricity to Host Fiscal First Quarter 2023 Financial Results Conference Call on August 15th at 4:30 p.m. ET
Via ACCESSWIRE
News headline image
Biotricity Reports Financial Results for Fiscal 2022 Fourth Quarter and Full Year
Company Reports Record Revenue and Improved Margins 
From Biotricity, Inc.
Via AccessWire
News headline image
Biotricity to Join Russell Microcap(R) Index
REDWOOD CITY, CA / ACCESSWIRE / June 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that the... 
From Biotricity, Inc.
Via AccessWire
News headline image
Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th
REDWOOD CITY, CA / ACCESSWIRE / May 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is scheduled to present... 
From Biotricity, Inc.
Via AccessWire
News headline image
Biotricity Issues Shareholder Update
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Biotricity, Inc.
Via AccessWire
News headline image
Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022
- Company reports pre-order sales from existing customers of its wireless wearable device for early detection of cardiac arrhythmias REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Biotricity, Inc.... 
From Biotricity, Inc.
Via AccessWire
Biotricity Inc. (NASDAQ: BTCY) Featured in Virtual Coverage of the 34th Annual Roth Conference
Via Investor Brand Network
News headline image
Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022
Leader in early-detection cardiac diagnostics monitoring solutions joins the ranks of Canva, Microsoft, SpaceX, and more REDWOOD CITY, CA / ACCESSWIRE / March 8, 2022 / Biotricity, Inc. (NASDAQ:BTCY)... 
From Biotricity, Inc.
Via AccessWire
News headline image
Biotricity, Inc. to Attend 34th Annual Roth Conference March 13th-15th
- Follows fiscal third quarter earnings that saw revenue up 93% year-over-year and Company's highest-ever quarterly cash position - Biotricity now taking preorders for Biotres, an FDA-cleared,... 
From Biotricity, Inc.
Via AccessWire
News headline image
Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device
- Announcement follows FDA clearance - Pre-Orders begin on February 23, 2022 with units shipping April 1, 2022 REDWOOD CITY, CA / ACCESSWIRE / February 23, 2022 / Biotricity, Inc. (NASDAQ:BTCY)... 
From Biotricity, Inc.
Via AccessWire
News headline image
Biotricity Releases Fiscal 2022 Third Quarter Financial Results
Management to host investor call on Tuesday February 15th at 4:15 pm ET - 93% YOY Revenue Gains to $1.93 Million - Revenue Outpaces SG&A Increase by 2.2x - Cash Position of $16.8 Million at Quarter End... 
From Biotricity, Inc.
Via AccessWire
News headline image
Biotricity to Report Third Quarter Fiscal 2022 Financial Results on February 14, 2022
Management to host call on Tuesday, February 15th at 4:15pm ET Sees Calendar-2022 as a breakout year with commercial launch of Bioheart and FDA clearance for Biotres REDWOOD CITY, CA / ACCESSWIRE /... 
From Biotricity, Inc.
Via AccessWire
News headline image
Biotricity Receives FDA 510(k) Clearance for its Biotres Cardiac Monitoring Device
Biotres is designed to continuously record ECG data for early detection of cardiac arrhythmias The Biotres addresses the $2 Billion-dollar holter market REDWOOD CITY, CA / ACCESSWIRE / January 24, 2022... 
From Biotricity, Inc.
Via AccessWire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.